Prandin® is an oral medication for diabetes management that contains repaglinide, a substance that enhances the production of insulin in the pancreas, resulting in reduced blood glucose levels.
Type 2 diabetes is a metabolic condition that causes inadequate insulin production by the pancreas or decreased sensitivity of the body's cells to insulin. Prandin® is prescribed to manage type 2 diabetes in adults who have not achieved optimal glycemic control through diet, exercise, and weight loss interventions alone. Prandin® is often used in combination with metformin, another antidiabetic medication.
The use of Prandin® has been demonstrated to reduce blood sugar levels, thereby reducing the risk of diabetes-related complications.